1 INTRODUCTION 63
1.1 STUDY OBJECTIVES 63
1.2 MARKET DEFINITION 63
1.2.1 INCLUSIONS AND EXCLUSIONS 63
1.3 MARKET SCOPE 64
1.3.1 MARKETS COVERED 64
1.3.2 YEARS CONSIDERED 65
1.3.3 CURRENCY CONSIDERED 66
1.4 STAKEHOLDERS 66
1.5 SUMMARY OF CHANGES 66
1.5.1 RECESSION IMPACT 67
2 RESEARCH METHODOLOGY 68
2.1 RESEARCH DATA 68
FIGURE 1 RESEARCH DESIGN 68
2.1.1 SECONDARY DATA 69
2.1.1.1 Key data from secondary sources 70
2.1.2 PRIMARY DATA 70
FIGURE 2 PRIMARY SOURCES 70
2.1.2.1 Key data from primary sources 71
2.1.2.2 Key industry insights 72
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 72
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 73
2.2 MARKET SIZE ESTIMATION 73
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 74
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 74
FIGURE 7 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: VETERINARY DIAGNOSTICS MARKET (2022) 75
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2023–2029) 76
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 77
FIGURE 10 TOP-DOWN APPROACH 78
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 79
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 79
2.4 MARKET SHARE ANALYSIS 80
2.5 ASSUMPTIONS 80
2.6 LIMITATIONS 80
2.7 RISK ASSESSMENT 81
TABLE 1 RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET 81
2.8 RECESSION IMPACT ANALYSIS 81
3 EXECUTIVE SUMMARY 82
FIGURE 12 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION) 82
FIGURE 13 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023 VS. 2029 (USD MILLION) 83
FIGURE 14 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2023 VS. 2029 (USD MILLION) 83
FIGURE 15 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 84
FIGURE 16 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2023 VS. 2029 (USD MILLION) 85
FIGURE 17 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 85
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET 86
4 PREMIUM INSIGHTS 87
4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW 87
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH 87
4.2 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2022) 88
FIGURE 20 VETERINARY REFERENCE LABORATORIES ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022 88
4.3 VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 89
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 89
4.4 VETERINARY DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 90
FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD 90
5 MARKET OVERVIEW 91
5.1 MARKET DYNAMICS 91
FIGURE 23 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 91
5.1.1 DRIVERS 92
5.1.1.1 Growth in companion animal population 92
TABLE 2 NUMBER OF US HOUSEHOLDS THAT OWN A PET, BY ANIMAL TYPE (MILLIONS) 92
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2022 (MILLION) 93
5.1.1.2 Rising demand for animal-derived food products 93
FIGURE 24 MAJOR PRODUCERS OF COW MILK WORLDWIDE IN 2022, BY COUNTRY (MILLION METRIC TONS) 94
TABLE 4 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES 94
TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 95
TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 95
5.1.1.3 Increasing incidence of transboundary and zoonotic diseases 96
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2023) 96
5.1.1.4 Rising demand for pet insurance and growing animal health expenditure 97
TABLE 8 US: AVERAGE ANNUAL PREMIUMS PAID (2020–2022) 98
FIGURE 25 US VS CANADA: GROSS WRITTEN PREMIUMS FOR DOGS, 2020–2022 (IN USD MILLION) 98
FIGURE 26 US VS CANADA: GROSS WRITTEN PREMIUMS FOR CATS, 2020–2022 (IN USD MILLION) 99
FIGURE 27 US: PET INDUSTRY EXPENDITURE, 2010–2022 99
TABLE 9 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020–2022 (USD BILLION) 100
TABLE 10 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2022 (USD MILLION) 100
5.1.1.5 Growing number of veterinary practitioners and rising income levels in developed economies 101
TABLE 11 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2020 101
5.1.1.6 Increasing disease control and prevention measures 101
5.1.2 RESTRAINTS 102
5.1.2.1 Rising pet care costs 102
FIGURE 28 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2022 102
5.1.2.2 High cost of veterinary diagnostic tests 103
5.1.3 OPPORTUNITIES 103
5.1.3.1 Untapped emerging markets 103
5.1.4 CHALLENGES 104
5.1.4.1 Lack of animal healthcare awareness in emerging countries 104
5.1.4.2 Shortage of veterinary practitioners in emerging economies 104
TABLE 12 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS 2014 VS 2018 105
5.2 INDUSTRY TRENDS 105
5.2.1 ADOPTION OF MULTIPLE TEST PANELS 105
TABLE 13 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS 105
5.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 106
5.2.3 GROWING CONSOLIDATION IN VETERINARY DIAGNOSTICS INDUSTRY 106
TABLE 14 MAJOR ACQUISITIONS IN ANIMAL HEALTH DIAGNOSTICS INDUSTRY 106
5.2.4 GROWING SCALE OF VETERINARY BUSINESSES 106
5.3 DISEASE TRENDS 107
5.3.1 LIVESTOCK 107
5.3.1.1 Avian Influenza 107
5.3.1.2 African Swine Fever 107
5.3.1.3 Bovine Babesiosis 107
5.3.1.4 Peste des Petits Ruminants 107
5.3.1.5 West Nile Virus 107
5.3.2 COMPANION ANIMALS 107
5.3.2.1 Zoonotic diseases 107
TABLE 15 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS 108
5.3.2.2 Obesity & diabetes 109
5.4 TECHNOLOGY ANALYSIS 109
5.4.1 KEY TECHNOLOGIES 109
5.4.1.1 Portable instruments for POC diagnostic services 109
TABLE 16 POC PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS AND MANUFACTURERS 109
5.4.2 ADJACENT TECHNOLOGIES 110
5.4.2.1 Rapid and sensitive veterinary diagnostic kits 110
5.4.3 COMPLEMENTARY TECHNOLOGIES 110
5.5 PRICING ANALYSIS 111
TABLE 17 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2022 (USD) 111
5.5.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION 112
TABLE 18 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP 3 APPLICATIONS (USD) 112
5.5.2 AVERAGE SELLING PRICE TRENDS, BY REGION 112
5.6 VALUE CHAIN ANALYSIS 112
FIGURE 29 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 113
5.7 ECOSYSTEM/MARKET MAP 113
FIGURE 30 VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP 114
5.8 PORTER’S FIVE FORCES ANALYSIS 114
TABLE 19 VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 114
5.8.1 THREAT OF NEW ENTRANTS 115
5.8.2 THREAT OF SUBSTITUTES 115
5.8.3 BARGAINING POWER OF SUPPLIERS 116
5.8.4 BARGAINING POWER OF BUYERS 116
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 116
5.9 SUPPLY CHAIN ANALYSIS 116
FIGURE 31 VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 118
5.10 TARIFF AND REGULATORY LANDSCAPE 118
5.10.1 REGULATORY ANALYSIS 118
5.10.1.1 US 118
5.10.1.2 Europe 119
5.10.1.3 Rest of the world 119
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120
5.10.2.1 North America 120
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120
5.10.2.2 Europe 122
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
5.10.2.3 Rest of the world 123
TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
5.11 PATENT ANALYSIS 123
5.11.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS 123
FIGURE 32 PATENT PUBLICATION TRENDS (JANUARY 2013-OCTOBER 2023) 124
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 124
FIGURE 33 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013–OCTOBER 2023) 125
FIGURE 34 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTICS PATENTS (JANUARY 2013–OCTOBER 2023) 125
5.12 KEY CONFERENCES AND EVENTS (2023–2025) 126
TABLE 23 VETERINARY DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 126
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 127
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 127
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS 127
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY DIAGNOSTICS 127
5.13.2 BUYING CRITERIA 128
FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 128
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 128
5.14 TRADE ANALYSIS 128
TABLE 26 TOP EXPORTERS OF VETERINARY DIAGNOSTIC CONSUMABLES (REAGENTS; COMPOSITE DIAGNOSTIC OR LABORATORY), 2022 129
5.15 CASE STUDIES 130
TABLE 27 INCREASE IN PATIENT VISITS AND DIAGNOSTIC PROCEDURES 130
TABLE 28 UNMET CUSTOMER NEEDS IN LIVESTOCK DIAGNOSTICS MARKET 130
TABLE 29 OPPORTUNITY ASSESSMENT IN HIGH-END AUTOMATED IMMUNOASSAY ANALYZERS IN COMPANION ANIMAL IMMUNODIAGNOSTICS 131
TABLE 30 IDENTIFICATION OF INTESTINAL PARASITE 131
5.16 ADJACENT MARKETS 131
FIGURE 37 VETERINARY DIAGNOSTICS MARKET: ADJACENT MARKETS 131
5.17 END-USER PERSPECTIVE & UNMET NEEDS 132
5.18 AI INTEGRATION IN VETERINARY DIAGNOSTICS 132
6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT 133
6.1 INTRODUCTION 134
TABLE 31 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 134
6.2 CONSUMABLES 134
6.2.1 CONSUMABLES TO HOLD LARGEST SHARE OF PRODUCTS MARKET 134
TABLE 32 KEY VETERINARY DIAGNOSTIC CONSUMABLES, BY COMPANY (2022) 135
TABLE 33 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 136
6.3 INSTRUMENTS 137
6.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET 137
TABLE 34 KEY VETERINARY DIAGNOSTIC INSTRUMENTS, BY COMPANY (2022) 137
TABLE 35 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 138
7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY 139
7.1 INTRODUCTION 140
TABLE 36 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 140
7.2 IMMUNODIAGNOSTICS 140
TABLE 37 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS, BY COMPANY 141
TABLE 38 VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 142
TABLE 39 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 143
7.2.1 LATERAL FLOW ASSAYS 143
TABLE 40 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 144
TABLE 41 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 144
7.2.1.1 Lateral flow rapid tests 145
7.2.1.1.1 Lateral flow rapid tests to dominate market 145
TABLE 42 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 145
7.2.1.2 Lateral flow strip readers 146
7.2.1.2.1 Rising need for readers to determine analyte quantity to drive adoption 146
TABLE 43 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 146
7.2.2 ELISA 147
7.2.2.1 Cost-effectiveness and ease of use to drive demand 147
TABLE 44 ELISA MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 147
7.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 148
7.2.3.1 Increasing incidence of allergies in companion animals to drive market growth 148
TABLE 45 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 148
7.2.4 IMMUNOASSAY ANALYZERS 149
7.2.4.1 Growing use of immunoassay analyzers for livestock to propel market 149
TABLE 46 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 149
7.2.5 RADIOIMMUNOASSAYS 150
7.2.5.1 Growing importance, high sensitivity & specificity to drive market 150
TABLE 47 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 150
7.2.6 OTHER IMMUNODIAGNOSTIC PRODUCTS 151
TABLE 48 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 151
7.3 CLINICAL BIOCHEMISTRY 152
TABLE 49 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS, BY COMPANY 152
TABLE 50 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 153
TABLE 51 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 154
7.3.1 CLINICAL CHEMISTRY ANALYSIS 154
TABLE 52 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 155
TABLE 53 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 155
7.3.1.1 Clinical chemistry reagent clips & cartridges 156
7.3.1.1.1 Rising number of screening tests performed to drive market 156
TABLE 54 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 156
7.3.1.2 Clinical chemistry analyzers 157
7.3.1.2.1 Increasing installations of clinical chemistry analyzers to propel growth 157
TABLE 55 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 157
7.3.2 GLUCOSE MONITORING 158
TABLE 56 GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 158
TABLE 57 GLUCOSE MONITORING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 159
7.3.2.1 Blood glucose strips 159
7.3.2.1.1 Growing demand for blood glucose strips in home care settings to drive market 159
TABLE 58 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 160
7.3.2.2 Glucose monitors 160
7.3.2.2.1 Growing incidence of diabetes in pet animals to drive adoption of glucose monitors 160
TABLE 59 GLUCOSE MONITORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 161
7.3.2.3 Urine glucose strips 162
7.3.2.3.1 Growing risk of DKA in animals to drive market 162
TABLE 60 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 162
7.3.3 BLOOD GAS & ELECTROLYTE ANALYSIS 163
TABLE 61 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 163
TABLE 62 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 164
7.3.3.1 Blood gas & electrolyte reagent clips & cartridges 165
7.3.3.1.1 Easy availability of animal species-specific preloaded reagent clips to boost market growth 165
TABLE 63 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 165
7.3.3.2 Blood gas & electrolyte analyzers 166
7.3.3.2.1 Growing adoption of analyzers to determine oxygen and carbon dioxide levels in blood to drive market 166
TABLE 64 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 166
7.4 MOLECULAR DIAGNOSTICS 167
TABLE 65 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 167
TABLE 66 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 168
7.4.1 PCR TESTS 169
7.4.1.1 Increased laboratory usage of PCR in proteomics and genomics to support growth 169
TABLE 67 PCR TESTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 169
7.4.2 MICROARRAYS 170
7.4.2.1 Growing applications of biochips in identifying infectious diseases to propel market 170
TABLE 68 MICROARRAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 171
7.4.3 NUCLEIC ACID SEQUENCING 172
7.4.3.1 Increased application of nucleic acid sequencing in diagnosis to drive market 172
TABLE 69 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 172
7.4.4 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 173
TABLE 70 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 173
7.5 URINALYSIS 174
TABLE 71 KEY VETERINARY URINALYSIS PRODUCTS, BY COMPANY 174
TABLE 72 VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 174
TABLE 73 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 175
7.5.1 URINALYSIS CLIPS & CARTRIDGES/PANELS 176
7.5.1.1 Growing use of clips and cartridges in urine analyzers to detect electrolytes to drive market 176
TABLE 74 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 176
7.5.2 URINE ANALYZERS 177
7.5.2.1 Development of easy-to-use urine analyzers for POC testing to drive market 177
TABLE 75 URINE ANALYZERS MARKET, BY COUNTRY, 2021–2029 USD MILLION) 177
7.5.3 URINE TEST STRIPS 178
7.5.3.1 Rising occurrence of kidney diseases in cats and dogs to support market 178
TABLE 76 URINE TEST STRIPS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 178
7.6 HEMATOLOGY 179
TABLE 77 KEY VETERINARY HEMATOLOGY PRODUCTS, BY COMPANY 179
TABLE 78 VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 179
TABLE 79 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 180
7.6.1 HEMATOLOGY CARTRIDGES 181
7.6.1.1 Extensive use of hematology cartridges along with hematology analyzers for complete blood analysis to fuel growth 181
TABLE 80 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 181
7.6.2 HEMATOLOGY ANALYZERS 182
7.6.2.1 High usage of hematology analyzers by veterinary hospitals & clinics to support growth 182
TABLE 81 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 182
7.7 OTHER TECHNOLOGIES 183
TABLE 82 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 183
8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE 184
8.1 INTRODUCTION 185
TABLE 83 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 185
8.2 COMPANION ANIMALS 185
TABLE 84 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 186
TABLE 85 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TECHNOLOGY, 2021–2029 (USD MILLION) 186
TABLE 86 VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2021–2029 (USD MILLION) 187
8.2.1 DOGS 187
8.2.1.1 High insurance coverage for dogs to drive market 187
TABLE 87 CANINE POPULATION, BY COUNTRY, 2014–2022 (MILLION) 188
TABLE 88 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2021–2029 (USD MILLION) 189
8.2.2 CATS 190
8.2.2.1 Growing pet cat population to support growth 190
TABLE 89 FELINE POPULATION, BY COUNTRY, 2012–2020 (MILLION) 190
TABLE 90 VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2021–2029 (USD MILLION) 191
8.2.3 HORSES 192
8.2.3.1 Growing equine health awareness to drive market 192
FIGURE 38 US: NUMBER OF PRIVATE EQUINE CLINICAL PRACTICES, 2009–2022 192
TABLE 91 VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2021–2029 (USD MILLION) 193
8.2.4 OTHER COMPANION ANIMALS 194
TABLE 92 VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2021–2029 (USD MILLION) 194
8.3 LIVESTOCK 195
TABLE 93 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 195
TABLE 94 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TECHNOLOGY, 2021–2029 (USD MILLION) 196
TABLE 95 VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2021–2029 (USD MILLION) 196
8.3.1 CATTLE 197
8.3.1.1 Growing consumption of meat to support market growth 197
FIGURE 39 MEAT PRODUCTION, BY TYPE, 2021–2022 (MILLION TONS) 197
FIGURE 40 MILK PRODUCTION, BY REGION, 2021–2022 (MILLION TONS) 198
TABLE 96 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2021–2029 (USD MILLION) 198
8.3.2 PIGS 199
8.3.2.1 Growing incidence of infectious diseases to drive market 199
FIGURE 41 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, EMERGING ECONOMIES VS. DEVELOPED COUNTRIES, 2020–2030 199
TABLE 97 VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2021–2029 (USD MILLION) 200
8.3.3 POULTRY 200
8.3.3.1 Increasing demand for poultry meat to contribute to market growth 200
TABLE 98 VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2021–2029 (USD MILLION) 201
8.3.4 OTHER LIVESTOCK 201
TABLE 99 VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK, BY COUNTRY, 2021–2029 (USD MILLION) 202
9 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION 203
9.1 INTRODUCTION 204
TABLE 100 VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 204
9.2 INFECTIOUS DISEASES 204
TABLE 101 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 204
TABLE 102 VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2029 (USD MILLION) 205
9.2.1 BACTERIAL INFECTIONS 206
9.2.1.1 Bacterial infections to hold largest share of infectious disease diagnostics 206
TABLE 103 VETERINARY DIAGNOSTICS MARKET FOR BACTERIAL INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION) 207
9.2.2 VIRAL INFECTIONS 207
9.2.2.1 High mutation rate to ensure continued demand for diagnostics 207
TABLE 104 VETERINARY DIAGNOSTICS MARKET FOR VIRAL INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION) 208
9.2.3 PARASITIC INFECTIONS 209
9.2.3.1 High prevalence of parasitic infections to propel demand 209
TABLE 105 VETERINARY DIAGNOSTICS MARKET FOR PARASITIC INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION) 210
9.2.4 OTHER INFECTIONS 211
TABLE 106 VETERINARY DIAGNOSTICS MARKET FOR OTHER INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION) 211
9.3 ENDOCRINOLOGY 212
9.3.1 GROWING RISK OF DIABETES TO SUPPORT DEMAND 212
TABLE 107 VETERINARY DIAGNOSTICS MARKET FOR ENDOCRINOLOGY, BY COUNTRY, 2021–2029 (USD MILLION) 212
9.4 CARDIOLOGY 213
9.4.1 RISING INCIDENCE OF CARDIAC DISEASES IN DOGS TO DRIVE MARKET 213
TABLE 108 VETERINARY DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2029 (USD MILLION) 213
9.5 ONCOLOGY 214
9.5.1 HIGH INCIDENCE OF CANINE CANCER TO DRIVE MARKET 214
TABLE 109 VETERINARY DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2029 (USD MILLION) 214
9.6 OTHER APPLICATIONS 215
TABLE 110 VETERINARY DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2029 (USD MILLION) 215
10 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 216
10.1 INTRODUCTION 217
TABLE 111 VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 217
10.2 DIRECT SALES 217
10.2.1 DIRECT SALES TO HOLD LARGEST MARKET SHARE 217
TABLE 112 VETERINARY DIAGNOSTICS MARKET FOR DIRECT SALES, BY COUNTRY, 2021–2029 (USD MILLION) 219
10.3 WHOLESALERS & DISTRIBUTORS 219
10.3.1 GROWING VOLUME OF INTERNATIONAL SALES TO SUPPORT SEGMENT GROWTH 219
TABLE 113 VETERINARY DIAGNOSTICS MARKET FOR WHOLESALERS & DISTRIBUTORS, BY COUNTRY, 2021–2029 (USD MILLION) 220
10.4 ONLINE SALES PLATFORMS 221
10.4.1 ONLINE SALES TO SEE HIGHEST GROWTH 221
TABLE 114 VETERINARY DIAGNOSTICS MARKET FOR ONLINE SALES PLATFORMS, BY COUNTRY, 2021–2029 (USD MILLION) 222
11 VETERINARY DIAGNOSTICS MARKET, BY END USER 223
11.1 INTRODUCTION 224
TABLE 115 VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 224
11.2 VETERINARY REFERENCE LABORATORIES 224
11.2.1 LARGE VOLUME OF SAMPLES RECEIVED BY VETERINARY REFERENCE LABORATORIES TO DRIVE MARKET GROWTH 224
TABLE 116 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2021–2029 (USD MILLION) 225
11.3 VETERINARY HOSPITALS & CLINICS 226
11.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET 226
FIGURE 42 US: VETERINARIAN CLINICAL PRACTICES, BY TYPE, 2022 226
TABLE 117 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION) 227
11.4 POC/IN-HOUSE TESTING 227
11.4.1 EASE OF USE, COST-EFFECTIVENESS, AND SWIFT RESULTS OFFERED BY POINT-OF-CARE TESTS TO DRIVE DEMAND 227
TABLE 118 VETERINARY DIAGNOSTICS MARKET FOR POC/IN-HOUSE TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 228
11.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 228
11.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES TO SUPPORT GROWTH 228
TABLE 119 VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2021–2029 (USD MILLION) 229
12 VETERINARY DIAGNOSTICS MARKET, BY REGION 230
12.1 INTRODUCTION 231
TABLE 120 VETERINARY DIAGNOSTICS MARKET, BY REGION, 2021–2029 (USD MILLION) 231
12.2 NORTH AMERICA 231
FIGURE 43 NORTH AMERICA: PROJECTED GROWTH IN NUMBER OF VETERINARIANS 232
12.2.1 NORTH AMERICA: RECESSION IMPACT 232
FIGURE 44 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 233
TABLE 121 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 234
TABLE 122 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 234
TABLE 123 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 234
TABLE 124 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 235
TABLE 125 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 235
TABLE 126 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 236
TABLE 127 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 236
TABLE 128 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 237
TABLE 129 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 237
TABLE 130 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 237
TABLE 131 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 238
TABLE 132 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 238
TABLE 133 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 238
TABLE 134 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 135 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 239
TABLE 136 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 240
TABLE 137 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 240
TABLE 138 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 241
TABLE 139 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 241
12.2.2 US 241
12.2.2.1 US to dominate North American market during forecast period 241
FIGURE 45 US: POPULATION OF DOGS, 2012–2022 (MILLION) 242
FIGURE 46 US: EXPENDITURE ON VET VISITS, 2013–2021 242
TABLE 140 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 VS 2021 242
FIGURE 47 US: VETERINARIAN INCOME LEVELS, 2017–2022 243
FIGURE 48 US: NUMBER OF VETERINARIANS, 2016–2021 243
TABLE 141 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 244
TABLE 142 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020 244
TABLE 143 US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 245
TABLE 144 US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 245
TABLE 145 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 246
TABLE 146 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 246
TABLE 147 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 247
TABLE 148 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 247
TABLE 149 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 247
TABLE 150 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 248
TABLE 151 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 248
TABLE 152 US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 248
TABLE 153 US: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 249
TABLE 154 US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 249
TABLE 155 US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 156 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 250
TABLE 157 US: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 250
TABLE 158 US: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 251
TABLE 159 US: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 251
TABLE 160 US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 252
12.2.3 CANADA 252
12.2.3.1 Growing pet adoption in Canada to drive market growth 252
FIGURE 49 CANADA: COMPANION ANIMAL POPULATION, 2020–2022 (MILLION) 253
TABLE 161 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 253
TABLE 162 CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 254
TABLE 163 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 254
TABLE 164 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 255
TABLE 165 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 255
TABLE 166 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 255
TABLE 167 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 256
TABLE 168 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 256
TABLE 169 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 257
TABLE 170 CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 257
TABLE 171 CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 257
TABLE 172 CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 258
TABLE 173 CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 174 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 175 CANADA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 259
TABLE 176 CANADA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 259
TABLE 177 CANADA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 259
TABLE 178 CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 260
12.3 EUROPE 260
TABLE 179 EUROPE: COMPANION POPULATION, 2022 (MILLION) 261
12.3.1 EUROPE: RECESSION IMPACT 262
TABLE 180 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 262
TABLE 181 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 262
TABLE 182 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 263
TABLE 183 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 263
TABLE 184 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 264
TABLE 185 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 264
TABLE 186 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 264
TABLE 187 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 265
TABLE 188 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 265
TABLE 189 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 265
TABLE 190 EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 266
TABLE 191 EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 266
TABLE 192 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 266
TABLE 193 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 194 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 195 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 268
TABLE 196 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 268
TABLE 197 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 268
TABLE 198 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 269
12.3.2.1 Rising awareness of zoonotic diseases to drive market growth 269
TABLE 199 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 270
TABLE 200 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 270
TABLE 201 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 271
TABLE 202 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 271
TABLE 203 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 272
TABLE 204 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 272
TABLE 205 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 272
TABLE 206 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 273
TABLE 207 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 273
TABLE 208 GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 273
TABLE 209 GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 274
TABLE 210 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 274
TABLE 211 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 274
TABLE 212 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 275
TABLE 213 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 275
TABLE 214 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 275
TABLE 215 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 276
TABLE 216 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 276
12.3.3 UK 276
12.3.3.1 Increasing pet ownership to drive market 276
TABLE 217 UK: HOUSEHOLDS WITH PETS (2022) 277
TABLE 218 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 278
TABLE 219 UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 278
TABLE 220 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 279
TABLE 221 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 279
TABLE 222 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 280
TABLE 223 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 280
TABLE 224 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 281
TABLE 225 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 281
TABLE 226 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 281
TABLE 227 UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 282
TABLE 228 UK: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 282
TABLE 229 UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 282
TABLE 230 UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 231 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 283
TABLE 232 UK: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 284
TABLE 233 UK: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 234 UK: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 284
TABLE 235 UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 285
12.3.4 FRANCE 285
12.3.4.1 Willingness of pet owners to spend on pet health to drive market 285
TABLE 236 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 286
TABLE 237 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 286
TABLE 238 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 287
TABLE 239 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 287
TABLE 240 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 288
TABLE 241 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 288
TABLE 242 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 289
TABLE 243 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 289
TABLE 244 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 290
TABLE 245 FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 290
TABLE 246 FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 290
TABLE 247 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 291
TABLE 248 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 291
TABLE 249 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 292
TABLE 250 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 292
TABLE 251 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 252 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 293
TABLE 253 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 294
12.3.5 ITALY 294
12.3.5.1 Rising awareness about pet healthcare to propel market growth 294
TABLE 254 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 295
TABLE 255 ITALY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 295
TABLE 256 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 296
TABLE 257 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 296
TABLE 258 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 259 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 297
TABLE 260 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 298
TABLE 261 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 298
TABLE 262 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 299
TABLE 263 ITALY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 299
TABLE 264 ITALY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 299
TABLE 265 ITALY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 300
TABLE 266 ITALY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 300
TABLE 267 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 268 ITALY: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 301
TABLE 269 ITALY: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 270 ITALY: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 302
TABLE 271 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 303
12.3.6 SPAIN 303
12.3.6.1 Growing demand for pig and poultry products to aid adoption of veterinary diagnostic products 303
TABLE 272 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 304
TABLE 273 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 304
TABLE 274 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 305
TABLE 275 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 305
TABLE 276 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 306
TABLE 277 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 306
TABLE 278 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 307
TABLE 279 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 307
TABLE 280 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 308
TABLE 281 SPAIN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 308
TABLE 282 SPAIN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 308
TABLE 283 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 309
TABLE 284 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 309
TABLE 285 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 310
TABLE 286 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 310
TABLE 287 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 288 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 311
TABLE 289 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 312
12.3.7 REST OF EUROPE 312
TABLE 290 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 313
TABLE 291 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 313
TABLE 292 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 314
TABLE 293 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 314
TABLE 294 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 315
TABLE 295 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 315
TABLE 296 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 315
TABLE 297 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 298 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 299 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 300 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 317
TABLE 301 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 317
TABLE 302 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 303 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 304 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 318
TABLE 305 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 306 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 319
TABLE 307 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 320
12.4 ASIA PACIFIC 320
12.4.1 ASIA PACIFIC: RECESSION IMPACT 320
FIGURE 50 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT 321
TABLE 308 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 322
TABLE 309 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 322
TABLE 310 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 323
TABLE 311 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 323
TABLE 312 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 324
TABLE 313 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 324
TABLE 314 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 325
TABLE 315 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 325
TABLE 316 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 326
TABLE 317 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 326
TABLE 318 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 327
TABLE 319 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 327
TABLE 320 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 327
TABLE 321 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 328
TABLE 322 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 328
TABLE 323 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 329
TABLE 324 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 329
TABLE 325 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 330
TABLE 326 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 330
12.4.2 CHINA 330
12.4.2.1 Large pool of food-producing animals in China to drive market 330
TABLE 327 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 331
TABLE 328 CHINA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 332
TABLE 329 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 332
TABLE 330 CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 333
TABLE 331 CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 333
TABLE 332 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 334
TABLE 333 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 334
TABLE 334 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 334
TABLE 335 CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 335
TABLE 336 CHINA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 335
TABLE 337 CHINA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 335
TABLE 338 CHINA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 336
TABLE 339 CHINA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 340 CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 336
TABLE 341 CHINA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 337
TABLE 342 CHINA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 337
TABLE 343 CHINA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 338
TABLE 344 CHINA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 338
12.4.3 JAPAN 338
12.4.3.1 Rising awareness about zoonotic diseases and increased pet expenditure to support adoption 338
FIGURE 51 JAPAN: FOOD, SNACK, AND MEDICAL EXPENDITURE FOR CATS AND DOGS (USD) 339
TABLE 345 NUMBER OF DOMESTICATED DOGS AND CATS IN JAPAN, 2012–2020 (THOUSAND) 339
TABLE 346 PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS) 340
TABLE 347 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 340
TABLE 348 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 341
TABLE 349 JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 341
TABLE 350 JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 342
TABLE 351 JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 342
TABLE 352 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 343
TABLE 353 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 343
TABLE 354 JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 344
TABLE 355 JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 344
TABLE 356 JAPAN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 344
TABLE 357 JAPAN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 345
TABLE 358 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 345
TABLE 359 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 345
TABLE 360 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 346
TABLE 361 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 346
TABLE 362 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 347
TABLE 363 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 347
TABLE 364 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 348
12.4.4 INDIA 348
12.4.4.1 Growing demand for livestock products to support market growth 348
TABLE 365 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 349
TABLE 366 INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 349
TABLE 367 INDIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 350
TABLE 368 INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 350
TABLE 369 INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 351
TABLE 370 INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 351
TABLE 371 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 351
TABLE 372 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 352
TABLE 373 INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 352
TABLE 374 INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 352
TABLE 375 INDIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 353
TABLE 376 INDIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 353
TABLE 377 INDIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 353
TABLE 378 INDIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 354
TABLE 379 INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 354
TABLE 380 INDIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 355
TABLE 381 INDIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 355
TABLE 382 INDIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 355
TABLE 383 INDIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 356
12.4.5 AUSTRALIA 356
12.4.5.1 Increase in pet ownership will support market growth 356
TABLE 384 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 357
TABLE 385 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 357
TABLE 386 AUSTRALIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 358
TABLE 387 AUSTRALIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 358
TABLE 388 AUSTRALIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 359
TABLE 389 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 359
TABLE 390 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 360
TABLE 391 AUSTRALIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 360
TABLE 392 AUSTRALIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 361
TABLE 393 AUSTRALIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 361
TABLE 394 AUSTRALIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 361
TABLE 395 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 362
TABLE 396 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 362
TABLE 397 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 362
TABLE 398 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 363
TABLE 399 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 363
TABLE 400 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 364
TABLE 401 AUSTRALIA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 364
12.4.6 SOUTH KOREA 365
12.4.6.1 Growing companion animal population to drive market 365
TABLE 402 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 365
TABLE 403 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 365
TABLE 404 SOUTH KOREA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 366
TABLE 405 SOUTH KOREA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 366
TABLE 406 SOUTH KOREA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 367
TABLE 407 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 367
TABLE 408 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 367
TABLE 409 SOUTH KOREA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 368
TABLE 410 SOUTH KOREA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 368
TABLE 411 SOUTH KOREA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 368
TABLE 412 SOUTH KOREA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 369
TABLE 413 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 369
TABLE 414 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 369
TABLE 415 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 370
TABLE 416 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 370
TABLE 417 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 371
TABLE 418 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 371
TABLE 419 SOUTH KOREA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 372
12.4.7 REST OF ASIA PACIFIC 372
TABLE 420 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 373
TABLE 421 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 373
TABLE 422 REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 374
TABLE 423 REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 374
TABLE 424 REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 375
TABLE 425 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 375
TABLE 426 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 375
TABLE 427 REST OF ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 376
TABLE 428 REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 376
TABLE 429 REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 376
TABLE 430 REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 377
TABLE 431 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 377
TABLE 432 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 377
TABLE 433 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 378
TABLE 434 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 378
TABLE 435 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 379
TABLE 436 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 379
TABLE 437 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 380
12.5 LATIN AMERICA 380
TABLE 438 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2022 (MILLION) 381
12.5.1 LATIN AMERICA: RECESSION IMPACT 381
TABLE 439 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 381
TABLE 440 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 382
TABLE 441 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 382
TABLE 442 LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 383
TABLE 443 LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 383
TABLE 444 LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 384
TABLE 445 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 384
TABLE 446 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 384
TABLE 447 LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 385
TABLE 448 LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 385
TABLE 449 LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 385
TABLE 450 LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 386
TABLE 451 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 386
TABLE 452 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 386
TABLE 453 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 387
TABLE 454 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 387
TABLE 455 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 388
TABLE 456 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 388
TABLE 457 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 389
12.5.2 BRAZIL 389
12.5.2.1 Well-established and rapidly growing livestock industry in Brazil to promote growth 389
TABLE 458 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 390
TABLE 459 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 390
TABLE 460 BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 391
TABLE 461 BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 391
TABLE 462 BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 392
TABLE 463 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 392
TABLE 464 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 393
TABLE 465 BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 393
TABLE 466 BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 394
TABLE 467 BRAZIL: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 394
TABLE 468 BRAZIL: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 394
TABLE 469 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 395
TABLE 470 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 395
TABLE 471 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 395
TABLE 472 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 396
TABLE 473 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 396
TABLE 474 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 397
TABLE 475 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 397
12.5.3 MEXICO 398
12.5.3.1 Mexico to retain second-largest share in Latin America till 2029 398
TABLE 476 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 398
TABLE 477 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029(USD MILLION) 398
TABLE 478 MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 399
TABLE 479 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY TYPE, 2021–2029 (USD MILLION) 399
TABLE 480 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 400
TABLE 481 MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 400
TABLE 482 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 401
TABLE 483 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 401
TABLE 484 MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 402
TABLE 485 MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 402
TABLE 486 MEXICO: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 403
TABLE 487 MEXICO: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 403
TABLE 488 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 403
TABLE 489 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 404
TABLE 490 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 404
TABLE 491 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 405
TABLE 492 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 405
TABLE 493 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 406
TABLE 494 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 406
12.5.4 REST OF LATIN AMERICA 406
TABLE 495 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 407
TABLE 496 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 407
TABLE 497 REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 408
TABLE 498 REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 408
TABLE 499 REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 409
TABLE 500 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 409
TABLE 501 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 410
TABLE 502 REST OF LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 410
TABLE 503 REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 411
TABLE 504 REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 411
TABLE 505 REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 411
TABLE 506 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 412
TABLE 507 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 412
TABLE 508 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 412
TABLE 509 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 413
TABLE 510 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 413
TABLE 511 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 414
TABLE 512 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 414
12.6 MIDDLE EAST & AFRICA 415
12.6.1 LOW PORK PRODUCTION AND CONSUMPTION IN MIDDLE EASTERN COUNTRIES DUE TO RELIGIOUS CUSTOMS TO LIMIT GROWTH 415
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 415
TABLE 513 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 416
TABLE 514 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021–2029 (USD MILLION) 416
TABLE 515 MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 417
TABLE 516 MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 417
TABLE 517 MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2021–2029 (USD MILLION) 418
TABLE 518 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 418
TABLE 519 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 419
TABLE 520 MIDDLE EAST & AFRICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 419
TABLE 521 MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 419
TABLE 522 MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 420
TABLE 523 MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 420
TABLE 524 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021–2029 (USD MILLION) 420
TABLE 525 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2021–2029 (USD MILLION) 421
TABLE 526 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2021–2029 (USD MILLION) 421
TABLE 527 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 422
TABLE 528 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY TYPE, 2021–2029 (USD MILLION) 422
TABLE 529 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021–2029 (USD MILLION) 423
TABLE 530 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2021–2029 (USD MILLION) 423
13 COMPETITIVE LANDSCAPE 424
13.1 OVERVIEW 424
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 424
13.3 REVENUE ANALYSIS 425
FIGURE 52 REVENUE ANALYSIS FOR KEY COMPANIES IN PAST FIVE YEARS 425
13.4 MARKET SHARE ANALYSIS 426
FIGURE 53 VETERINARY DIAGNOSTICS MARKET: MARKET SHARE ANALYSIS, 2022 426
13.5 COMPANY EVALUATION MATRIX 427
13.5.1 STARS 427
13.5.2 EMERGING LEADERS 427
13.5.3 PERVASIVE PLAYERS 428
13.5.4 PARTICIPANTS 428
FIGURE 54 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX, 2022 428
13.5.5 COMPANY FOOTPRINT 429
TABLE 531 PRODUCT FOOTPRINT 429
TABLE 532 TECHNOLOGY FOOTPRINT 430
TABLE 533 END-USER FOOTPRINT 431
TABLE 534 REGION FOOTPRINT 432
TABLE 535 COMPANY FOOTPRINT 433
13.6 START-UP/SME EVALUATION MATRIX 434
13.6.1 PROGRESSIVE COMPANIES 434
13.6.2 DYNAMIC COMPANIES 434
13.6.3 STARTING BLOCKS 434
13.6.4 RESPONSIVE COMPANIES 434
FIGURE 55 VETERINARY DIAGNOSTICS MARKET: START-UP/SME EVALUATION MATRIX (2022) 435
13.6.5 COMPETITIVE BENCHMARKING 436
13.7 COMPETITIVE SCENARIO 436
13.7.1 PRODUCT LAUNCHES 437
TABLE 536 PRODUCT LAUNCHES 437
13.7.2 DEALS 437
TABLE 537 DEALS 437
13.7.3 OTHER DEVELOPMENTS 438
TABLE 538 OTHER DEVELOPMENTS 438
14 COMPANY PROFILES 439
14.1 KEY PLAYERS 439
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 IDEXX LABORATORIES, INC. 439
TABLE 539 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW 439
FIGURE 56 IDEXX LABORATORIES: COMPANY SNAPSHOT (2022) 440
14.1.2 ZOETIS, INC. 448
TABLE 540 ZOETIS, INC.: COMPANY OVERVIEW 448
FIGURE 57 ZOETIS, INC.: COMPANY SNAPSHOT (2022) 449
14.1.3 THERMO FISHER SCIENTIFIC, INC. 455
TABLE 541 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW 455
FIGURE 58 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (20222) 456
14.1.4 HESKA CORPORATION (MARS INCORPORATED) 466
TABLE 542 HESKA CORPORATION: COMPANY OVERVIEW 466
FIGURE 59 HESKA CORPORATION: COMPANY SNAPSHOT (2022) 467
14.1.5 BIOMÉRIEUX SA 470
TABLE 543 BIOMÉRIEUX SA: COMPANY OVERVIEW 470
FIGURE 60 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022) 471
14.1.6 NEOGEN CORPORATION 476
TABLE 544 NEOGEN CORPORATION: COMPANY OVERVIEW 476
FIGURE 61 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022) 477
14.1.7 BIO-RAD LABORATORIES, INC. 482
TABLE 545 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 482
FIGURE 62 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 483
14.1.8 VIRBAC 486
TABLE 546 VIRBAC: COMPANY OVERVIEW 486
FIGURE 63 VIRBAC: COMPANY SNAPSHOT (2022) 486
14.1.9 FUJIFILM HOLDINGS CORPORATION 489
TABLE 547 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 489
FIGURE 64 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 490
14.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD. 491
TABLE 548 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 491
FIGURE 65 MINDRAY GROUP: COMPANY SNAPSHOT (2022) 491
14.1.11 INDICAL BIOSCIENCE GMBH 493
TABLE 549 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW 493
14.1.12 BIONOTE INC. 496
TABLE 550 BIONOTE INC.: COMPANY OVERVIEW 496
14.1.13 BIOGAL GALED LABS 498
TABLE 551 BIOGAL GALED LABS: COMPANY OVERVIEW 498
14.1.14 AGROLABO S.P.A. 500
TABLE 552 AGROLABO S.P.A.: COMPANY OVERVIEW 500
14.1.15 INNOVATIVE DIAGNOSTICS 506
TABLE 553 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW 506
14.2 OTHER PLAYERS 513
14.2.1 RANDOX LABORATORIES LTD. 513
14.2.2 BIOCHEK 514
14.2.3 FASSISI GMBH 514
14.2.4 ALVEDIA 515
14.2.5 SKYER, INC. 515
14.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 516
14.2.7 PRECISION BIOSENSOR 516
14.2.8 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 517
14.2.9 GOLD STANDARD DIAGNOSTICS 517
14.2.10 ANTECH DIAGNOSTICS, INC. 518
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 519
15.1 DISCUSSION GUIDE 519
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 525
15.3 CUSTOMIZATION OPTIONS 527
15.4 RELATED REPORTS 527
15.5 AUTHOR DETAILS 528
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
